medroxyprogesterone has been researched along with Papilloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furnari, S; Mattea, E; Pavone-Macaluso, M; Veroux, G | 1 |
| Ringrose, CA | 1 |
2 other study(ies) available for medroxyprogesterone and Papilloma
| Article | Year |
|---|---|
Cancer chemotherapy in urology.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Chlorambucil; Cobalt; Dactinomycin; Dysgerminoma; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Papilloma; Prostatic Neoplasms; Teratoma; Testicular Neoplasms; Testosterone; Thiotepa; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vincristine; Wilms Tumor | 1971 |
Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
Topics: Adult; Body Weight; Breast; Breast Neoplasms; Chemical Phenomena; Chemistry; Contraceptive Agents; Endometrium; Fallopian Tubes; Female; Fertility; Humans; Injections; Medroxyprogesterone; Menstruation; Ovary; Papilloma; Parity; Time Factors; Vagina; Vaginal Smears | 1972 |